<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999155/" ref="ordinalpos=756&amp;ncbi_uid=6068514&amp;link_uid=PMC3999155" image-link="/pmc/articles/PMC3999155/figure/ppat-1004041-g006/" class="imagepopup">Figure 6. Working model of TRAF3-dependent regulation of RLR <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> by HSCARG..  From: HSCARG Negatively Regulates the Cellular Antiviral RIG-I Like Receptor <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span> by Inhibiting TRAF3 Ubiquitination via Recruiting OTUB1. </a></div><br /><div class="p4l_captionBody">Followed viral infection, HSCARG interacts with TRAF3, and cooperates with OTUB1 to remove Lys63-linked polyubiquitin chain from TRAF3. This further decreases the recruitment of IKKε and results in decreased phosphorylation of IKKε and IRF3, and finally reduces the production of IFN-β.</div></div>